Works matching DE "CHIRON Corp."
1
- Nature, 1997, v. 385, n. 6619, p. 760, doi. 10.1038/385760c0
- Article
2
- Nature, 1995, v. 378, n. 6556, p. 425
- Article
3
- Nature, 1995, v. 375, n. 6526, p. 8, doi. 10.1038/375008c0
- Article
4
- Nature, 1994, v. 372, n. 6508, p. 814, doi. 10.1038/372814a0
- Article
5
- Nature, 1994, v. 372, n. 6506, p. 485, doi. 10.1038/372485a0
- Article
6
- Nature, 1994, v. 372, n. 6506, p. 487, doi. 10.1038/372487a0
- Article
7
- Nature, 1994, v. 370, n. 6490, p. 493, doi. 10.1038/370493a0
- Article
8
- Financial Executive, 2003, v. 19, n. 1, p. 64
- Article
9
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 22, p. 2709, doi. 10.1001/jama.293.22.2709-a
- Article
10
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 2, p. 151, doi. 10.1001/jama.293.2.151-b
- Article
11
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 14, p. 1670, doi. 10.1001/jama.292.14.1670
- Article
12
- Dispute Resolution Journal, 2000, v. 55, n. 3, p. 91
- Article
13
- American Family Physician, 2004, v. 70, n. 9, p. 1625
- Article
14
- American Family Physician, 2004, v. 70, n. 8, p. 1433
- Article
15
- Clinical Infectious Diseases, 2005, v. 40, n. 8, p. 1
- Article
16
- Clinical Infectious Diseases, 2004, v. 39, n. 6, p. 1
- Article
17
- Nature Medicine, 2004, v. 10, n. 11, p. 1148, doi. 10.1038/nm1104-1148a
- Article
18
- Nature Medicine, 2003, v. 9, n. 10, p. 1230, doi. 10.1038/nm1003-1230b
- Article
19
- Bio-IT World, 2004, v. 3, n. 9, p. 1
- Article
20
- Nature Reviews Drug Discovery, 2005, v. 4, n. 12, p. 948, doi. 10.1038/nrd1919
- Article
21
- Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1394
- Article
22
- Applied Clinical Trials, 2000, v. 9, n. 4, p. 16
- Article
23
- American Nurse, 2004, v. 36, n. 6, p. 10
- Article
24
- Chemistry & Industry, 2006, n. 5, p. 5
- Article
25
- Chemistry & Industry, 2005, n. 21, p. 12
- Article
26
- Chemistry & Industry, 2005, n. 21, p. 4
- Article
27
- Chemistry & Industry, 2005, n. 6, p. 7
- Article
28
- Chemistry & Industry, 2003, n. 18, p. 4
- Article
29
- Research Technology Management, 1995, v. 38, n. 5, p. 14, doi. 10.1080/08956308.1995.11674290
- Article
30
- Research Technology Management, 1993, v. 36, n. 5, p. 14
- Article
31
- Nature, 2005, v. 437, n. 7058, p. 475, doi. 10.1038/437475a
- Article
32
- Nature, 2005, v. 437, n. 7056, p. 191, doi. 10.1038/437191b
- Article
33
- Nature, 2004, v. 431, n. 7010, p. 726, doi. 10.1038/431726a
- Article
34
- Nature Reviews Immunology, 2004, v. 4, n. 11, p. 836, doi. 10.1038/nri1511
- Article
35
- Journal of Commercial Biotechnology, 2002, v. 9, n. 1, p. 85, doi. 10.1057/palgrave.jcb.3040012
- Crocker, Glenn;
- Oliver, Oan
- Article
36
- Nature Biotechnology, 2005, v. 23, n. 12, p. 1463, doi. 10.1038/nbt1205-1463
- Article
37
- Nature Biotechnology, 2005, v. 23, n. 10, p. 1191, doi. 10.1038/nbt1005-1191
- Article
38
- Nature Biotechnology, 2004, v. 22, n. 12, p. 1487, doi. 10.1038/nbt1204-1487
- Article
40
- Nature Biotechnology, 2003, v. 21, n. 10, p. 1125, doi. 10.1038/nbt1003-1125
- Article
41
- Nature Biotechnology, 2003, v. 21, n. 7, p. 717, doi. 10.1038/nbt0703-717
- Article
42
- Nature Biotechnology, 2000, v. 18, n. 10, p. 1023, doi. 10.1038/80137
- Article
43
- Nature Biotechnology, 1998, v. 16, n. 13, p. 1308, doi. 10.1038/4269
- Article
44
- Nature, 1991, v. 352, n. 6334, p. 364, doi. 10.1038/352364a0
- Article
45
- Medical Laboratory Observer (MLO), 2005, v. 37, n. 1, p. 8
- Article
46
- Medical Laboratory Observer (MLO), 1999, v. 31, n. 12, p. 9
- Article
47
- Medical Laboratory Observer (MLO), 1998, v. 30, n. 11, p. 56
- Article
48
- Drugs in R&D, 2006, v. 7, n. 5, p. 312
- Article
49
- Cambridge Quarterly of Healthcare Ethics, 2003, v. 12, n. 4, p. 429, doi. 10.1017/s0963180103124127
- Article